Shinva Medical Instrument Co Ltd
SSE:600587

Watchlist Manager
Shinva Medical Instrument Co Ltd Logo
Shinva Medical Instrument Co Ltd
SSE:600587
Watchlist
Price: 14.2 CNY Market Closed
Market Cap: ¥8.6B

Shinva Medical Instrument Co Ltd's latest stock split occurred on Jul 21, 2014

The company executed a 2-for-1 stock split, meaning that for every share held, investors received 2 new shares.

Before the split, Shinva Medical Instrument Co Ltd traded at 64.95 per share. Afterward, the share price was about 31.9514.

The adjusted shares began trading on Jul 21, 2014. This was Shinva Medical Instrument Co Ltd's 4th stock split, following the previous one in Apr 23, 2012.

Last Splits:
Jul 21, 2014
2-for-1
Apr 23, 2012
1420-for-1273
Jun 24, 2008
13-for-10
Jun 30, 2003
7-for-5
Pre-Split Price
31.3079 64.95
Post-Split Price
31.9514
Before
After
Last Splits:
Jul 21, 2014
2-for-1
Apr 23, 2012
1420-for-1273
Jun 24, 2008
13-for-10
Jun 30, 2003
7-for-5

Shinva Medical Instrument Co Ltd
Stock Splits History

Shinva Medical Instrument Co Ltd Stock Splits Timeline
Jul 21, 2014
Jul 21, 2014
Split 2-for-1
x2
Pre-Split Price
31.3079 64.95
Post-Split Price
31.9514
Before
After
Apr 23, 2012
Apr 23, 2012
Split 1420-for-1273
x1.1154752553024
Pre-Split Price
N/A
Post-Split Price
10.2862
Before
After
Jun 24, 2008
Jun 24, 2008
Split 13-for-10
x1.3
Pre-Split Price
N/A
Post-Split Price
10.2862
Before
After
Jun 30, 2003
Jun 30, 2003
Split 7-for-5
x1.4
Pre-Split Price
N/A
Post-Split Price
10.2862
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Apr 24, 2026
Cue Biopharma Inc
NASDAQ:CUE
1-for-30
/30
0.5542 16.626 USD 17.695 17.695 USD
Apr 24, 2026
Medical Data Vision Co Ltd
TSE:3902
2-for-7253607
/3626803.5
1684 1684 JPY N/A
Apr 24, 2026
E
ESGL Holdings Ltd
NASDAQ:ESGL
1-for-3
/3
2.35 7.05 USD 2.93 2.93 USD
Apr 24, 2026
Metro Mining Ltd
ASX:MMI
1-for-20
/20
0.067 1.34 AUD 1.3 1.3 AUD
Apr 24, 2026
L
La Comer SAB de CV
OTC:LCMRF
115-for-114
x1.0087719298246
2.4715 2.4341 USD 2.45 2.45 USD
Load More

Shinva Medical Instrument Co Ltd
Glance View

Market Cap
8.6B CNY
Industry
Health Care

In the brisk hustle of China's healthcare evolution, Shinva Medical Instrument Co., Ltd. stands as a pivotal player, navigating the intricate world of medical devices and pharmaceutical machinery since its inception in 1943. Rooted deeply in the tangible yet transformative realm of healthcare technology, Shinva has advanced from its initial focus on producing pharmaceutical sterilization equipment to a comprehensive provider of medical solutions. With its headquarters in the tech-driven province of Shandong, Shinva operates in various sectors, providing a multifaceted approach to healthcare. The company’s operations span across diverse segments including medical devices, environmental protection equipment, and pharmaceutical engineering services, ensuring it remains adaptive to contemporary medical demands and regulatory standards. Revenue flows primarily from the design, manufacture, and distribution of medical and laboratory equipment, widening its customer base from local hospitals to international healthcare facilities. Shinva’s portfolio is intriguingly broad, encompassing products that range from high-end sterilization tools and radiation therapy equipment to diagnostic imaging and surgical instruments. This diversification safeguards the company against market volatility while aligning with the ever-increasing demand for efficiency and safety in medical procedures. Moreover, its commitment to research and development underscores its strategic mission to innovate and refine healthcare delivery systems, anchoring its status as a leader in the industry. This adaptability and relentless pursuit of quality enable Shinva to thrive, aptly positioning it to grow alongside China's expansive healthcare sector.

Intrinsic Value
27.41 CNY
Undervaluation 48%
Intrinsic Value
Price ¥14.2
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett